Rituximab use for lymphoplasmacytic lymphoma during continuous renal replacement therapy

Rituximab safety and efficacy in patients with renal impairment have not been established, nor have the effects of hemodialysis on serum rituximab level. There are only a few published case reports assessing serum rituximab level pre- and postdialysis. No data have been published regarding the usage...

Descripción completa

Detalles Bibliográficos
Autores principales: Simões, Marco, Miranda, Marisa, Carda, José, Carmo, Anália, Martins, Paulo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Medicina Intensiva Brasileira - AMIB 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649227/
https://www.ncbi.nlm.nih.gov/pubmed/31271628
http://dx.doi.org/10.5935/0103-507X.20190040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649227/
https://www.ncbi.nlm.nih.gov/pubmed/31271628
http://dx.doi.org/10.5935/0103-507X.20190040

Ejemplares similares